SUPN Intrinsic Valuation and Fundamental Analysis - Supernus Pharmaceuticals Inc

	Supernus Pharmaceuticals Inc NASDAQ:SUPN	US
A	ASML Holding NV XMUN:ASME	NL

Intrinsic Value

The intrinsic value for Supernus Pharmaceuticals Inc (SUPN) under the Base Case is 38.89 USD. Compared with the current market price of 46.991 USD, the stock appears Overvalued by 17% .

Intrinsic value calculated using Multiples

$38.89

Other reference points

DCF valuation

$49.569

Wall St target

$64.77

Do our valuations actually work? See backtest results .

SUPN Intrinsic Value

Overvaluation 17%

Intrinsic Value

Price $46.991

Loading...

What is Valuation History?

Track Buy Zone

20% below Intrinsic Value $31.11

Get notified when the price drops into your buy zone

Current Price $46.99

Intrinsic Value $38.89

Margin of Safety 20% $31.11

Or choose another margin of safety

0% below Intrinsic Value

10% below Intrinsic Value

30% below Intrinsic Value

40% below Intrinsic Value

50% below Intrinsic Value

Custom

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations

Let our AI break down the key assumptions behind the intrinsic value calculation for Supernus Pharmaceuticals Inc.

Explain Valuation